Fei-Pi (Phoebe) Lin, MD

  • Clinical Assistant Professor of Medicine
  • Co-Director, UPMC Wilson Disease Center of Excellence
Academic Interests

My academic interests center on the comprehensive care of patients with liver disease across the full disease spectrum. I am particularly interested in the assessment of frailty in patients with chronic liver disease and the development of prehabilitation strategies to optimize functional status and improve liver transplant outcomes. Clinically, I focus on the management of chronic liver diseases, including the care of patients with decompensated cirrhosis and portal hypertension. I also perform endoscopic procedures, including upper endoscopy and colonoscopy, as part of the diagnostic and therapeutic management of these patients. I have a dedicated interest in the multidisciplinary management of Wilson disease, collaborating closely with neurology to provide coordinated, patient-centered care. In addition to my clinical work, I am committed to medical education and mentorship. As the subspecialty education coordinator for the division, I actively work with residents and fellows, with a focus on fostering clinical reasoning, professional development, and career mentorship.

    Education & Training

  • BS, Neuroscience, College of William and Mary, 2015
  • MD, Virginia Commonwealth University School of Medicine, 2019
  • Internal Medicine Residency, University of Pittsburgh School of Medicine, 2021
  • Clinical Fellowship, Gastroenterology and Hepatology, University of Pittsburgh School of Medicine, 2025
  • Clinical Fellowship, Transplant Hepatology, University of Pittsburgh School of Medicine, 2025
Recent Publications

Mohy-Ud-Din N, Lin FP, Rachakonda V, Al-Khafaji A, Biggins SW, Ganesh S, Bataller R, DiMartini A, Hughes C, Humar A, Malik SM. Expedited liver transplantation as first-line therapy for severe alcohol hepatitis: ELFSAH; deferring corticosteroids in the sickest subset of patients. Clin Transplant. 2024 Jul;38(7):e15340. PMID: 39049597.

Lin FP, Bloomer PM, Grubbs RK, Rockette-Wagner B, Tevar AD, Dunn MA, Duarte-Rojo A. Low Daily Step Count Is Associated With a High Risk of Hospital Admission and Death in Community-Dwelling Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2022 Aug;20(8):1813-1820.e2. PMID: 35331941. 

Lin FP, Visina JM, Bloomer PM, Dunn MA, Josbeno DA, Zhang X, Clemente-Sanchez A, Tevar AD, Hughes CB, Jakicic JM, Duarte-Rojo A. Prehabilitation-Driven Changes in Frailty Metrics Predict Mortality in Patients With Advanced Liver Disease. Am J Gastroenterol. 2021 Oct 1;116(10):2105-2117. PMID: 34313620.

Lin FP, Ferrando AA, Dennis RA, Dunn MA, Kim WR, Duarte-Rojo A. Exercise-Induced Hyperammonemia Does Not Precipitate Overt Hepatic Encephalopathy. Hepatology. 2020 Aug;72(2):778-780. PMID: 31997375.

Patel SS, Lin FP, Rodriguez VA, Bhati C, John BV, Pence T, Siddiqui MB, Sima AP, Abbate A, Reichman T, Siddiqui MS. The relationship between coronary artery disease and cardiovascular events early after liver transplantation. Liver Int. 2019 Jul;39(7):1363-1371. PMID: 30848862.

    Honors and Awards
  • YIF Scholar, Controversies in Transplant, 2024 and 2025
  • People’s Choice Award, American Liver Foundation, 2024
  • Emerging Liver Scholar, American Association for the Study of Liver Diseases, 2021
  • Phi Beta Kappa, College of William and Mary, 2015